Universities play an important role in inspiring diversity among new generations of entrepreneurs and innovators to improve the innovation ecosystem. Providing underrepresented researchers with access to opportunities and networks can bring the needed change to better reflect the diversity of our nation and to tip the scale toward equity and inclusion in innovation.
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.
Four Rutgers professors have been named fellows of the American Association for the Advancement of Science (AAAS), joining 485 others as a result of their efforts to advance science or its applications.
Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel.
Regardless of who wins the 2020 presidential election, the American people can expect the U.S. Senate to push back on unilateral actions by either President Trump or President Biden, more than it did during Trump’s first term, according to John J. Farmer, Jr. director of Rutgers University’s Eagleton Institute of Politics. He discusses these possibilities in the latest installment of "What Happens Next: Election Edition."
At Rutgers' Office for Research, we are proud and grateful for the extraordinary efforts and work of our researchers to improve lives. Their discipline, persistence and commitment, in good and in challenging times, are a testament to the excellence that Rutgers aspires to achieve every day. Thank you, Champions!
Rutgers-led study NJ HEROES TOO focuses on the Black and Latinx communities disproportionately affected by COVID-19 in places where Rutgers academic medical centers are deeply rooted
A new state-of-the-art brain-imaging scanner for advanced exploration into the workings of the human brain - a Siemens PRISMA functional magnetic resonance imaging (fMRI) scanner - will soon be available to researchers at the Rutgers University Brain Imaging Center thanks to a National Science Foundation grant in combination with matching funds from Rutgers University.
A novel base editing technology invented at Rutgers, with the potential to be used for the creation of new cell and gene therapies, will be made available to researchers worldwide through an exclusive partnership with the Horizon Discovery Group.
